Cholinesterase inhibitor drugs (still sold to treat Alzheimer's) were designed to increase acetylcholine availability based on the hypothesis that acetylcholine deficiency was the primary problem; however, this is 'multiple steps down the line' in the causal chain—the true problem is that the brain is starting to contract and lose functionality ('downsizing').

causalpending

Speaker

David Perlmutter

Evidence Quote

“that's not the cause that's the that's multiple steps down the line when the brain is starting to contract and lose its functionality”

Source

A Comprehensive Plan For Alzheimer's - with Dr. Dale Bredesen | The Empowering Neurologist EP. 53— DavidPerlmutterMD
Created: 8/12/2026, 10:24:53 PM

Your notes

Loading notes...